Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Literature
1.
Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM et al (2016) The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 127:2391–2405CrossRefPubMed
2.
Gralnick HR, Harbor J, Vogel C (1971) Myelofibrosis in chronic granulocytic leukemia. Blood. 37:152–162CrossRef
3.
Thiele J, Kvasnicka HM, Facchetti F, Franco V, van der Walt J, Orazi A (2005) European consensus on grading bone marrow fibrosis and assessment of cellularity. Haematologica. 90:1128–1132PubMed
4.
Neuendorff NR, Burmeister T, Dörken B, Westermann J (2016) BCR-ABL-positive acute myeloid leukemia: a new entity? Analysis of clinical and molecular features. Ann Hematol 95:1211–1221CrossRefPubMed
5.
Döhner H, Estey E, Grimwade D, Amadori S, Appelbaum FR, Büchner T, Dombret H, Ebert BL, Fenaux P, Larson RA, Levine RL, Lo-Coco F, Naoe T, Niederwieser D, Ossenkoppele GJ, Sanz M, Sierra J, Tallman MS, Tien HF, Wei AH, Löwenberg B, Bloomfield CD (2017) Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 129:424–447CrossRefPubMedPubMedCentral
6.
Buesche G, Hehlmann R, Hecker H, Heimpel H, Heinze B, Schmeil A et al (2003) Marrow fibrosis, indicator of therapy failure in chronic myeloid leukemia - prospective long-term results from a randomized-controlled trial. Leukemia. 17:2444–2453CrossRefPubMed
7.
Dekmezian R, Kantarjian HM, Keating MJ, Talpaz M, McCredie KB, Freireich EJ (1987) The relevance of reticulin stain-measured fibrosis at diagnosis in chronic myelogenous leukemia. Cancer. 59:1739–1743CrossRefPubMed
8.
Bueso-Ramos CE, Cortes J, Talpaz M, O’Brien S, Giles F, Rios MB, Medeiros LJ, Kantarjian H (2004) Imatinib mesylate therapy reduces bone marrow fibrosis in patients with chronic myelogenous leukemia. Cancer. 101:332–336CrossRefPubMed
Metadata
Title
BCR-ABL1- and CBFB-MYH11-positive chronic myeloid leukemia presenting with primary blast crisis and marrow fibrosis
Authors
Keisuke Kidoguchi
Kensuke Kojima
Masako Yokoo
Shinya Kimura
Publication date
01-10-2019
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 10/2019
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-019-03779-8

Other articles of this Issue 10/2019

Annals of Hematology 10/2019 Go to the issue

Letter to the Editor

Pomalidomide-based maintenance post-autologous hematopoietic cell transplantation in multiple myeloma: a case series

Original Article

Effect of adjunctive corticosteroid on 28-day mortality in neutropenic patients with septic shock

Letter to the Editor

Acute myeloid leukemia presenting as bilateral adrenal hemorrhage

Original Article

Genetic characterization of pediatric primary hemophagocytic lymphohistiocytosis in China: a single-center study

Original Article

Frequency of silent brain lesions and aspirin protection evaluation over 3 years follow-up in beta thalassemia patients

Original Article

Association of plasma homocysteine level with vaso-occlusive crisis in sickle cell anemia patients of Odisha, India
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits